# Frequency-specific microcurrent Rating: Early — Mostly animal or cell studies; few or uncontrolled human data Type: Therapy Updated: 2026-10-15 Canonical: https://heretic.bio/articles/frequency-specific-microcurrent.html > Frequency-specific microcurrent delivers sub-sensory microamp current through paired frequencies claimed to target specific tissues and conditions. The generic microcurrent underneath has real trial support, an 8-RCT wound-healing meta-analysis and a double-masked palatal-surgery trial, plus one striking FSM trial in muscle soreness. The frequency-pair specificity that defines FSM remains unproven. > **Core thesis:** Microcurrent therapy uses very low-amperage electrical stimulation, usually below sensory threshold, to interact with endogenous wound currents and cell membrane signaling. The broader microcurrent wound-healing literature has randomized trials and a meta-analysis; the narrower **frequency-specific microcurrent** (FSM) system has intriguing but still preliminary evidence, including a small randomized DOMS study and uncontrolled pilot data in systemic sclerosis/Raynaud's. * * * ## Overview **Frequency-specific microcurrent (FSM)** is a subset of microcurrent electrical stimulation that applies microampere-level current through two channels, each carrying selected frequency patterns. Practitioners claim that one channel encodes a tissue or organ target and the other encodes a condition or pathology. This claim is more specific than the general bioelectric rationale for microcurrent and should be treated with more skepticism. The most defensible framing is: 1. **Microcurrent itself is biologically plausible** because tissues generate endogenous electrical fields during development and repair. 2. **Wound-healing microcurrent has human RCT evidence** , including a 2022 meta-analysis of randomized clinical trials (PMID: [34903470](https://pubmed.ncbi.nlm.nih.gov/34903470/)). 3. **FSM frequency-pair specificity is less proven** ; current evidence is a mix of small studies, mechanistic hypotheses, clinical case reports, and practitioner experience. 4. **Risk is usually low when used conservatively** , but devices and protocols vary widely, and claims often outrun data. Related files: [Electromagnetic Therapies](electromagnetic-therapies.html), [Overview - Regenerative Medicine](regenerative-medicine-overview.html), [Peptide Therapy for Injuries](peptide-therapy-for-injuries.html), [Overview - Photobiomodulation](red-light-therapy.html), [Mitochondrial Health](mitochondrial-health.html). * * * ## Definitions ### Microcurrent Microcurrent electrical therapy generally uses currents in the **microampere** range, often ~10–1,000 μA. Unlike TENS, which is usually felt as tingling or muscle stimulation, microcurrent is commonly sub-sensory. ### Frequency-Specific Microcurrent FSM usually refers to a clinical system popularized by Carolyn McMakin and colleagues. It combines: * **Microampere current** rather than milliampere TENS intensity * **Two-channel frequency pairs** rather than one generic pulse setting * **Condition/tissue frequency tables** derived largely from historical practice and clinician observation * **Hands-on application** with graphite gloves, wet towels, or adhesive electrodes ### Bioelectricity Bioelectricity is not mystical: ion gradients, membrane potentials, endogenous wound currents, epithelial voltage gradients, and injury potentials are measurable biological phenomena. The contested part is whether externally applied consumer or clinic devices can reliably reproduce useful, tissue-specific instructions. * * * ## Mechanisms of Action ### 1\. Endogenous Wound Currents Injury disrupts epithelial barriers and creates local electric fields. Cells involved in repair — keratinocytes, fibroblasts, macrophages, endothelial cells — can respond to electric-field direction and intensity. A conservative hypothesis is that microcurrent augments or organizes these weak repair signals. ### 2\. Cell Membrane and Ion Channel Effects Low-level electrical stimulation can plausibly influence membrane potential, calcium flux, ATP demand, and nitric-oxide-related vascular tone. This does not require accepting the strongest FSM claims about exact disease frequencies; it only requires that cells are electrically excitable and electrochemically organized. ### 3\. ATP and Protein Synthesis Claims A frequently cited older experiment by Cheng et al. reported increased ATP generation, amino-acid transport, and protein synthesis in rat skin exposed to low-level current. This study is often quoted in marketing as “ATP increases 300–500%.” Useful caveats: * It was **preclinical** , not a human outcome trial. * Effects depended on current intensity; more current was not automatically better. * The finding supports plausibility, not universal clinical efficacy. ### 4\. Anti-Inflammatory Signaling Small FSM studies and practitioner reports often focus on rapid pain reduction and tissue softening. Possible non-exclusive explanations: * reduced sympathetic tone * local vasodilation and improved perfusion * altered inflammatory mediators * descending pain modulation * placebo/contextual effects from a relaxing hands-on session ### 5\. Fascia, Tone, and “Tissue Softening” McMakin and Oschman describe rapid palpable tissue softening and warming during FSM sessions (PMID: [22775307](https://pubmed.ncbi.nlm.nih.gov/22775307/); PMCID: [PMC3576917](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576917/)). This is clinically interesting but mechanistically unresolved. The phenomenon could reflect changes in muscle tone, autonomic state, local fluid dynamics, practitioner perception, or some combination. * * * ## Evidence at a Glance Application | Evidence strength | Notes ---|---|--- Wound healing, general microcurrent | **Moderate** | Meta-analysis of RCTs found reduced wound area and healing time, but trial quality/protocol reporting varied (PMID [34903470](https://pubmed.ncbi.nlm.nih.gov/34903470/)). Palatal wound healing after graft harvest | **Moderate** | Double-masked RCT, n=53; faster closure/epithelialization and less early pain (PMID [32783220](https://pubmed.ncbi.nlm.nih.gov/32783220/)). Delayed-onset muscle soreness (DOMS), FSM | **Preliminary positive RCT** | Within-subject leg control, n=35; large VAS differences at 24–72h (PMID [20538225](https://pubmed.ncbi.nlm.nih.gov/20538225/)). Systemic sclerosis hand function/Raynaud's, FSM | **Pilot only** | Two small pilot studies, n=17; rapid improvements; needs randomized sham-controlled follow-up (PMID [40465410](https://pubmed.ncbi.nlm.nih.gov/40465410/)). Chronic pain/fibromyalgia FSM | **Suggestive but weak** | Case series and mechanistic papers; susceptible to selection, expectation, and practitioner effects. Claims that exact frequencies target exact organs/pathologies | **Unproven** | Central FSM claim; not yet established to the same standard as electrical wound-healing effects. * * * ## Key Human Studies ### Delayed-Onset Muscle Soreness RCT Curtis et al. tested FSM after eccentric hamstring exercise in 35 healthy participants (PMID: [20538225](https://pubmed.ncbi.nlm.nih.gov/20538225/)). One leg received 20 minutes of FSM and the other leg served as control. Reported soreness was much lower in the treated leg: Time after exercise | Treated leg | Control leg | p-value ---|---|---|--- 24h | 1.3 ± 1.0 | 5.2 ± 1.3 | 0.0005 48h | 1.2 ± 1.1 | 7.0 ± 1.1 | 0.0005 72h | 0.7 ± 0.6 | 4.0 ± 1.6 | 0.0005 **Interpretation:** The effect size is striking, but the model is acute exercise soreness in healthy volunteers. It does not automatically generalize to tendon tears, neuropathy, chronic pain syndromes, or systemic inflammatory disease. ### Wound Healing Meta-Analysis A 2022 meta-analysis of randomized clinical trials examined electrical microcurrent therapy for acute and chronic wounds (PMID: [34903470](https://pubmed.ncbi.nlm.nih.gov/34903470/)). It included 8 RCTs qualitatively and 7 in quantitative analysis, with 337 total participants. Compared with standard wound care alone, microcurrent plus standard wound care improved: * **Wound surface area:** mean difference −8.3 cm², 95% CI −10.5 to −6.0 * **Healing time:** mean difference −7.0 days, 95% CI −11.9 to −2.1 * **Pain:** mean difference −1.4 points, 95% CI −2.7 to −0.2 The authors rated certainty as moderate for wound surface reduction, low for healing time, and very low for number of wounds healed. ### Palatal Wound Healing RCT A double-masked randomized clinical trial of 53 patients after free gingival graft harvest found that microcurrent electrotherapy accelerated palatal wound closure and epithelialization, reduced pain at 3 days, and improved early oral-health quality-of-life scores (PMID: [32783220](https://pubmed.ncbi.nlm.nih.gov/32783220/)). **Interpretation:** This supports microcurrent as a wound-healing adjunct in a defined surgical injury model. It does not prove FSM's frequency-pair theory. ### Systemic Sclerosis / Raynaud's Pilot Studies Gregory et al. reported two pilot studies of FSM in 17 systemic sclerosis patients with hand dysfunction and Raynaud's symptoms (PMID: [40465410](https://pubmed.ncbi.nlm.nih.gov/40465410/)). After 45–60 minutes of treatment over 1–2 days, hand function improved ~40% in combined analyses and Raynaud's VAS improved 18/100 points. **Interpretation:** The rapid effect is notable and biologically plausible if vascular tone or soft tissue stiffness changed, but the study was small and not definitive. It is best treated as a signal for sham-controlled trials. * * * ## Practical Notes ### General Session Parameters Typical clinical microcurrent/FSM sessions use: Parameter | Range in the literature | Notes ---|---|--- Current | ~10–1,000 μA | Often below sensory threshold. More is not necessarily better. Session length | 20–60 minutes | Acute soreness studies used 20 minutes; clinical FSM often longer. Frequency | Device/protocol-dependent | FSM uses paired frequencies; generic MENS may use simpler pulse settings. Application | Electrodes, wet towels, graphite gloves | Hydration and skin contact quality change current delivery. Course | Acute: 1–3 sessions; chronic: repeated trials | Stop if no measurable response after a reasonable trial. ### Conservative Trial Framework For self-experimentation or clinic evaluation, use an N-of-1 structure: 1. **Define one target outcome** — pain VAS, range of motion, wound size, grip strength, sleep disruption, HRV. 2. **Collect baseline** for 3–7 days when possible. 3. **Keep other interventions stable** — avoid adding [BPC-157 (Body Protection Compound)](bpc-157-body-protection-compound.html), [Overview - Photobiomodulation](red-light-therapy.html), sauna, or new supplements simultaneously. 4. **Use sham/blinding if possible** — e.g., have someone else set active/sham sessions when the device permits. 5. **Track durability** — immediate pain relief is less meaningful than retained function over days/weeks. 6. **Stop for adverse reactions** — unusual pain flares, skin irritation, palpitations, dizziness, or neurological symptoms. ### Possible Use Cases Most plausible: * post-procedure wound discomfort * delayed-onset muscle soreness * chronic wounds under professional care * localized soft tissue pain where TENS is too stimulating * adjunct to rehab when pain blocks movement More speculative: * fibromyalgia and central sensitization * Raynaud's / vasospasm syndromes * scar remodeling * neuropathic pain * visceral conditions claimed by FSM practitioners ### Contraindications and Cautions Avoid or use only with qualified clinical guidance in: * implanted electrical devices such as pacemakers or defibrillators * pregnancy, especially over abdomen/pelvis * active malignancy over treatment area unless oncology team approves * seizure disorders if applying near head/neck * broken skin unless device/protocol is intended for wound care * acute infection where delayed medical treatment would be dangerous Microcurrent should not substitute for urgent care in fracture, deep infection, tendon rupture, ischemia, progressive neurological deficit, or non-healing ulcers. * * * ## Relationship to Other Regenerative Modalities ### Compared with TENS TENS is primarily analgesic and usually uses milliampere currents that the patient can feel. Microcurrent is lower intensity and is framed as reparative rather than only analgesic. In practice, both may reduce pain; the distinction matters because pain relief is not the same as tissue healing. ### Compared with PEMF [PEMF](electromagnetic-therapies.html) induces electrical fields magnetically and can reach deeper tissues without skin electrodes. Microcurrent passes current through surface contact points. PEMF has stronger regulatory history for bone non-unions; microcurrent has a more wound-focused evidence base. ### Compared with Photobiomodulation [Photobiomodulation](red-light-therapy.html) targets cytochrome c oxidase and redox signaling using light. Microcurrent targets electrical gradients and membrane signaling. Both are low-energy modalities with plausible mitochondrial links and both suffer from heterogeneous device parameters. ### Compared with Peptides [Peptide Therapy for Injuries](peptide-therapy-for-injuries.html) attempts to alter repair signaling chemically. Microcurrent attempts to alter repair signaling electrically. Combining them may make sense mechanistically, but stacking interventions makes it difficult to know what worked. * * * ## Critical Analysis ### What Seems Real * Endogenous electrical fields participate in wound healing. * Microcurrent has RCT-level support as an adjunct for some wound-healing contexts. * At least one FSM DOMS study showed large short-term effects. * Low-intensity electrical therapies are underexplored partly because they do not fit the pharmaceutical IP/reimbursement model. ### What Remains Unproven * Whether FSM frequency tables correspond to objective tissue/pathology resonances. * Whether rapid tissue softening predicts durable healing. * Which frequencies, currents, waveforms, and placements are necessary versus ritualized practitioner tradition. * Whether benefits exceed contextual/placebo effects for chronic pain conditions. ### Red Flags in the Field * claims to cure cancer, Lyme, autism, or chronic infections without controlled data * proprietary frequency lists treated as secret knowledge rather than testable hypotheses * lack of published parameters, making replication impossible * selling expensive devices while citing only preclinical ATP claims * using symptom relief as proof of structural repair * * * ## Research Leads * Replicate the DOMS study with sham control, concealed allocation, and objective markers such as creatine kinase, force recovery, ultrasound elastography, and inflammatory cytokines. * Run a randomized sham-controlled FSM trial for Raynaud's with digital perfusion imaging and cold challenge. * Compare generic microcurrent vs FSM frequency pairs to test whether the frequency-specific component adds anything. * Standardize reporting: waveform, current, frequency, electrode placement, tissue impedance, treatment duration, and co-interventions. * Examine whether microcurrent synergizes with [Overview - Photobiomodulation](red-light-therapy.html) or [Hyperbaric Oxygen Therapy](hyperbaric-oxygen-therapy-hbot.html) in wound models. * * * ## Notes * The library should eventually separate **generic microcurrent electrical stimulation** from **FSM** if enough material accumulates. Right now they are combined because much of the practical overlap is device/protocol-based. * The strongest current evidence is for wound-healing adjunct use, not for broad chronic disease claims. * The most important unresolved question is whether specific frequency pairs add benefit beyond low-level electrical stimulation plus practitioner attention. * Future update: retrieve full-text protocol parameters from the wound-healing RCTs and add a parameter comparison table. * * * **Related:** [Electromagnetic Therapies](electromagnetic-therapies.html) | [Overview - Regenerative Medicine](regenerative-medicine-overview.html) | [Peptide Therapy for Injuries](peptide-therapy-for-injuries.html) | [Overview - Photobiomodulation](red-light-therapy.html) | [Mitochondrial Health](mitochondrial-health.html) | [Hyperbaric Oxygen Therapy](hyperbaric-oxygen-therapy-hbot.html) ## Sources 1. Poltawski L, et al. Electrical microcurrent stimulation therapy for wound healing: A meta-analysis of randomized clinical trials. J Tissue Viability. 2022. PMID: 34903470 . (PubMed 34903470) 2. McMakin CR, Oschman JL. Visceral and somatic disorders: tissue softening with frequency-specific microcurrent. J Altern Complement Med. 2013;19(2):170-177. PMID: 22775307 . PMCID: PMC3576917 . (PubMed 22775307, PMC3576917) 3. Krey AO, et al. Microcurrent electrotherapy improves palatal wound healing: randomized clinical trial. J Periodontol. 2021. PMID: 32783220 . (PubMed 32783220) 4. Curtis D, Fallows S, Morris M, McMakin C. The efficacy of frequency specific microcurrent therapy on delayed onset muscle soreness. J Bodyw Mov Ther. 2010;14(3):272-279. PMID: 20538225 . (PubMed 20538225) 5. Gregory WM, Bagley K, Eng S, McMakin C, Del Galdo F. Frequency-specific microcurrent improves hand function and Raynaud's symptoms in scleroderma: results of two pilot studies. Rheumatology (Oxford). 2025. PMID: 40465410 . (PubMed 40465410)